Editas Medicine, Inc.·4

Jun 6, 4:16 PM ET

Mei Baisong 4

4 · Editas Medicine, Inc. · Filed Jun 6, 2024

Insider Transaction Report

Form 4
Period: 2024-06-04
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2024-06-04$5.50/sh511$2,808141,032 total
Footnotes (1)
  • [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.

Documents

1 file
  • 4
    wk-form4_1717704962.xmlPrimary

    FORM 4